Doxorubicin Hydrochloride: clinical trials recruiting now

Fewer than 3 recruiting trials found.

2

Recruiting trials

8

Conditions studied

13

US states with sites

4

Countries

Phase breakdown

Early Phase 1 1 Phase 2 1

Conditions being studied

Condition	Trials
Ann Arbor Stage I Diffuse Large B-Cell Lymphoma	1
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma	1
Ann Arbor Stage III Diffuse Large B-Cell Lymphoma	1
Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma	1
Breast Cancer	1
Breast Neoplasms	1
HIV	1
Plasmablastic Lymphoma	1

Recruiting trials involving Doxorubicin Hydrochloride

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
NCT04139304 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
NCT06797635 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 17 locations

Common questions

How many recruiting trials involve Doxorubicin Hydrochloride?

2 recruiting trials across 8 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.